RecruitingPhase 2NCT07037420
ALXN2420 Versus Placebo in Combination With Somatostatin Analogs in Participants With Acromegaly
Studying Acromegaly
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Alexion Pharmaceuticals, Inc.
- Intervention
- ALXN2420(drug)
- Enrollment
- 60 enrolled
- Eligibility
- 18-80 years · All sexes
- Timeline
- 2025 – 2027
Study locations (30)
- Research Site, Los Angeles, California, United States
- Research Site, Torrance, California, United States
- Research Site, Aurora, Colorado, United States
- Research Site, Boston, Massachusetts, United States
- Research Site, Ann Arbor, Michigan, United States
- Research Site, Las Vegas, Nevada, United States
- Research Site, New York, New York, United States
- Research Site, Portland, Oregon, United States
- Research Site, CABA, Argentina
- Research Site, Ciudad de Buenos Aires, Argentina
- Research Site, Curitiba, Brazil
- Research Site, Ribeirão Preto, Brazil
- Research Site, Rio de Janeiro, Brazil
- Research Site, São Paulo, Brazil
- Research Site, Beijing, China
- +15 more locations on ClinicalTrials.gov
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07037420 on ClinicalTrials.govOther trials for Acromegaly
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE3NCT06930625A Study to Assess the Efficacy and Safety of Debio 4126 in Participants With Acromegaly Previously Treated With Somatostatin AnalogsDebiopharm International SA
- RECRUITINGNCT07179926Effects of Pasireotide Lar Therapy on Bone MetabolismFondazione Policlinico Universitario Agostino Gemelli IRCCS
- RECRUITINGPHASE1NCT07195175Study of MAR002 in Healthy MenMarea Therapeutics
- RECRUITINGNCT06597383The RApid Switch From 1st Generation Somatostatin Analogues to PaSireOtiDe In AcromegalyIRCCS San Raffaele
- RECRUITINGNANCT06949891KETOgenic Diet Therapy in Patients With ACROmegalyErasmus Medical Center
- RECRUITINGNCT06344650Cellular, Molecular and Clinical Determinants of Bone Strength in in Vivo and Human Models of GH Excess.IRCCS San Raffaele
- RECRUITINGNCT05131100Korean Regulatory Post Marketing Surveillance for SomavertPfizer
- ACTIVE NOT RECRUITINGPHASE3NCT05192382A Study to Evaluate the Safety and Efficacy of Paltusotine for the Treatment of Acromegaly (PATHFNDR-2)Crinetics Pharmaceuticals Inc.